Citation Impact
Citing Papers
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
2012
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
2009
Burn wound healing and treatment: review and advancements
2015 Standout
Double-blind randomized study of tramadol vs. paracetamol in analgesia after day-case tonsillectomy in children
2000
Pain Intensity on the First Day after Surgery
2013 Standout
Preemptive analgesia with tramadol and fentanyl in pediatric neurosurgery
2000
An Evaluation of the Efficacy and Tolerability of Oral Tramadol Hydrochloride Tablets for the Treatment of Postsurgical Pain in Children
2002
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting
2010
Emerging targets in neuroinflammation-driven chronic pain
2014
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
2006
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
2015
Schizophrenia
2009 Standout
Relief of posttonsillectomy pain with low-dose tramadol given at induction of anesthesia in children
2000
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
New approaches and challenges to targeting the endocannabinoid system
2018
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial
2014
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
2015
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Pathological pain and the neuroimmune interface
2014
Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
2016 Standout
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial
2012
Osteoarthritis
2015 Standout
The Erector Spinae Plane Block
2016 Standout
Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?
2014
Analgesic efficacy of tramadol 2 mg kg−1 for paediatric day-case adenoidectomy
2001
Gut microbiome and health: mechanistic insights
2022 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Immunosuppressive Effects of Opioids—Clinical Relevance
2011
Opioide bei chronischem neuropathischem Schmerz
2014
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Glia and pain: Is chronic pain a gliopathy?
2013
Immunopathology of multiple sclerosis
2015 Standout
Oral or transdermal opioids for osteoarthritis of the knee or hip
2009
Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice
2014
Cannabis, the mind and society: the hash realities
2007
Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials
2007
Outcomes Associated with Opioid Use in the Treatment of Chronic Noncancer Pain in Older Adults: A Systematic Review and Meta‐Analysis
2010
Treatment of Chronic Non-Malignant Pain in the Elderly
2009
A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
2011
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
2007
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
2012
Clinical Pharmacology of Tramadol
2004 Standout
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
2009
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
2012
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Osteoarthritis
2019 Standout
Tramadol
2000
Pharmacotherapy of neuropathic pain
2015
Cannabinoids and the expanded endocannabinoid system in neurological disorders
2019
Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study
2014
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review
2015
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
2010
Are cannabinoids more effective than placebo in decreasing MS-related bladder dysfunction?
2012
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Double-blind randomized study of tramadol vs. paracetamol in analgesia after day-case tonsillectomy in children
2000
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances
2007
Between China and South Asia: A Middle Asian corridor of crop dispersal and agricultural innovation in the Bronze Age
2016 Standout
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
2010
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
2018
Cannabinoids for Medical Use
2015 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
An Evaluation of the Efficacy and Tolerability of Oral Tramadol Hydrochloride Tablets for the Treatment of Postsurgical Pain in Children
2002
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Oral or transdermal opioids for osteoarthritis of the knee or hip
2014
Tramadol for osteoarthritis
2006
Works of S. Ratcliffe being referenced
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
2007
The respiratory effects of tramadol in children under halothane anaesthesia
1998
Intraindividual Differences in Pain Relief and Functional Improvement in Osteoarthritis with Diclofenac or Tramadol
1998
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
2012
Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo‐controlled trial
2006
A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia
2013
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
2011
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
2010
A double‐blind, randomized, placebo‐controlled, parallel group study of THC /CBD spray in peripheral neuropathic pain treatment
2014
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
2011
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
2016